We use cookies to give you the best possible user experience. This message will not display again. To find out more, see our cookie policy.
This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.
Regulations require that clinical trials be adequately monitored for GCP compliance by a suitably trained/qualified monitor. However, monitoring of non-commercial trials does not always need the intensity traditionally employed by the pharmaceutical industry.
The R&D team can provide monitoring, or help you find an appropriate monitor. It is essential that monitoring costs are included in funding applications.